Healthcare - Medical - Devices - NASDAQ - US
$ 2.59
-2.26 %
$ 2.37 M
Market Cap
-0.31
P/E
CASH FLOW STATEMENT
-6.07 M
OPERATING CASH FLOW
-125 K
INVESTING CASH FLOW
10.3 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Heart Test Laboratories, Inc.
| Net Income | -6.61 M |
| Depreciation & Amortization | 95.1 K |
| Capital Expenditures | -125 K |
| Stock-Based Compensation | 405 K |
| Change in Working Capital | -504 K |
| Others | 171 K |
| Free Cash Flow | -6.2 M |
Cash Flow
Millions
| Apr-2024 | Apr-2023 | Apr-2022 | Apr-2021 | Apr-2020 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (6.6) | (6.4) | (4.8) | (2.5) | (3.8) |
| Depreciation & Amortization | 95.1 K | 26.9 K | 26.6 K | 33.6 K | 63.8 K |
| Deferred Income Tax | 0 | 101.1 | 0 | 0 | 10 K |
| Stock Based Compensation | 0.4 | 0.2 | 68.4 K | 24.7 K | 0.1 |
| Other Operating Activities | 0.5 | (101.0) | 35.6 K | (0.2) | 21.8 K |
| Change in Working Capital | (0.5) | 0.2 | 1.1 | 0.2 | (0.2) |
| Cash From Operations | (6.1) | (5.8) | (3.6) | (2.5) | (3.8) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (0.1) | 18.3 K | 1.93 K | 712 | 11.4 K |
| Other Items | 0 | 0 | 0 | 0 | 19.6 K |
| Cash From Investing Activities | (0.1) | 18.3 K | 1.93 K | 712 | 8.17 K |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 42.6 K | (0.4) | 4.2 | 2.5 | 0.6 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 1.3 | (0.4) | 0.2 | 1.2 |
| Cash From Financing Activities | 10.3 | 6.5 | 3.8 | 2.7 | 1.8 |
| CHANGE IN CASH | |||||
| Net Change In Cash | 4.1 | 0.7 | 0.2 | 0.2 | (2.0) |
| FREE CASH FLOW | |||||
| Free Cash Flow | (6.2) | (5.8) | (3.6) | (2.5) | (3.9) |